Oaktree Capital Group Holdings GP LLC 13D and 13G filings for BioXcel Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-12-18 8:19 pm Purchase |
2024-11-25 | 13G | BioXcel Therapeutics, Inc. BTAI |
Oaktree Capital Group Holdings GP LLC | 170,255 5.200% |
170,255 (New Position) |
Filing |